Literature DB >> 27856239

Discovery of novel multi-target indole-based derivatives as potent and selective inhibitors of chikungunya virus replication.

Maria Scuotto1, Rana Abdelnabi2, Selene Collarile1, Chiara Schiraldi1, Leen Delang2, Antonio Massa3, Salvatore Ferla4, Andrea Brancale4, Pieter Leyssen2, Johan Neyts2, Rosanna Filosa5.   

Abstract

We recently identified indole derivatives (IIIe and IIIf) with anti-chikungunya virus (CHIKV) activities at lower micro molar concentrations and a selective index of inhibition higher than the lead compound Arbidol. Here we highlight new structural information for the optimization of the previously identified lead compounds that contain the indole chemical core. Based on the structural data, a series of indole derivatives was synthesized and tested for their antiviral activity against chikungunya virus in Vero cell culture by a CPE reduction assay. Systematic optimization of the lead compounds resulted in tert-butyl-5-hydroxy-1-methyl-2-(2-trifluoromethysulfynyl)methyl)-indole-3-carboxylate derivative IIc with a 10-fold improved anti-CHIKV inhibitory activity (EC50=6.5±1μM) as compared to Arbidol demonstrating a potent, selective and specific inhibition of CHIKV replication with only a moderate cell protective effect against other related alphaviruses. The reported computational insights, together with the accessible synthetic procedure, pave the road towards the design of novel synthetic derivatives with enhanced anti-viral activities.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arbidol; Chikungunya; Replication; Virus

Mesh:

Substances:

Year:  2016        PMID: 27856239     DOI: 10.1016/j.bmc.2016.10.037

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Structure-based optimization and synthesis of antiviral drug Arbidol analogues with significantly improved affinity to influenza hemagglutinin.

Authors:  Zoë V F Wright; Nicholas C Wu; Rameshwar U Kadam; Ian A Wilson; Dennis W Wolan
Journal:  Bioorg Med Chem Lett       Date:  2017-06-28       Impact factor: 2.823

2.  Synthesis and Bioactivity Evaluation of N-Arylsulfonylindole Analogs Bearing a Rhodanine Moiety as Antibacterial Agents.

Authors:  Ming-Xia Song; Song-Hui Li; Jiao-Yang Peng; Ting-Ting Guo; Wen-Hui Xu; Shao-Feng Xiong; Xian-Qing Deng
Journal:  Molecules       Date:  2017-06-14       Impact factor: 4.411

Review 3.  The medicinal chemistry of Chikungunya virus.

Authors:  Edeildo F da Silva-Júnior; Giovanni O Leoncini; Érica E S Rodrigues; Thiago M Aquino; João X Araújo-Júnior
Journal:  Bioorg Med Chem       Date:  2017-06-29       Impact factor: 3.641

4.  Chikungunya virus time course infection of human macrophages reveals intracellular signaling pathways relevant to repurposed therapeutics.

Authors:  Madison Gray; Israel Guerrero-Arguero; Antonio Solis-Leal; Richard A Robison; Bradford K Berges; Brett E Pickett
Journal:  PeerJ       Date:  2022-03-21       Impact factor: 2.984

5.  Synthesis and Biological Evaluation of Umifenovir Analogues as Anti-SARS-CoV-2 Agents.

Authors:  Hiroaki Tanaka; Seiya Miyagi; Yusuke Yoshida; Justin Steven Lamb; Christian Nanga Chick; Lokadi Pierre Luhata; Mizuho Shibata; Eri Tanaka; Yumiko Suzuki; Toyonobu Usuki
Journal:  ChemistrySelect       Date:  2022-08-09       Impact factor: 2.307

Review 6.  Antivirals against the Chikungunya Virus.

Authors:  Verena Battisti; Ernst Urban; Thierry Langer
Journal:  Viruses       Date:  2021-07-05       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.